Determination of FHIT and CDKN2A Promoter Methylation Levels in Hazak's Esophageal Cancer Tissue Based on Methylation-sensitive High Resolution Melting Analysis and Its Clinical Significance
LI Hui,LIU Ling,WANG Hongjiang,CHEN Yan,PANG Zuoliang,JIANG Xiaofang,WU Jun,LI Xiumei,MA Lili,ZHOU Bo,LI Huiwu
DOI: https://doi.org/10.3981/j.issn.1000-7857.2011.31.009
2011-01-01
Abstract:The promoter methylation of tumor suppressor gene is one of the most important mechanisms of tumorigenesis.The method of Methylation-Sensitive High-Resolution Melting-curve(MS-HRM) analysis was used to analyze methylation differences at the FHIT,CDKN2A locus in DNA samples from individuals with Esophageal Cancer(EC) (n=30) and adjacent normal tissues(n=30) .After extracting and modifying DNA by methylating-agents,the standard DNA samples were mixed with the completely methylated DNA to make the dilute methyled DNAs of 0%,5%,25%,50%,75%,and 100%,respectively.And then their sensitivity and repeatability were evaluated.Using HRM,the methylation level was detected.And the relation between the methylation levels of FHIT and CDKN2A promoters and the development of EC is discussed.The high-resolution melting-curves of 100%,80%,50%,30%,10%,and 0% methylated DNA are decreasingly arranged from right to left,the locations on the standard curve denote the methylation level.The lowest detection limit of HRM is 1%,and it is more sensitive than the 10% detection limit of MSP.With the MS-HRM assay,36.7% of the FHIT promoters(11/30) are methylated.Among them,there are eight cases with methylation level between 0%—5%,and three cases with methylation level between 5%—10%.100% of the CDKN2A promoters(30/30) are methylated.There are seven cases with methylation level between 0%—5%,11 cases with methylation level between 5%—10%,and 12 cases with methylation level between 10%—25%.Compared with the adjacent normal tissues,there is no significant relationship between the methylation and the development of the Hazak's EC.There is no significant relationship either between the methylation and the TNM or between methylation and differentiation of two genes in the Hazak's esophageal cancer.It is found that the MS-HRM is a simple,rapid,and robust method for screening methylation differences at the FHIT,CDKN2A locus;furthermore the more suppressor genes will be screened and found as the early diagnostic markers.